http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007014124-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad5c752d0c9f5fc1ce9e2f80320aa501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d55444126b55e1edeb40523a4818da76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d674e25b19dab2778a581048efe5fe4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1174ce1fb9f3d7fe82c3fee5468cef8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b56ea6f989a46c51a9cf002ba7b34329
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5fc9a82eeab2db1ad8a2d209ac6a0887
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13
filingDate 2006-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab06e0ff5410016938b072ecc1ab3682
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf6411df38b3e409ffeab0499bf8ad0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9081baa03a383b90dad1541e38515381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a311a21aa0819de2b72eaa8aa2bfefa2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e4c8652fb4bf58655e0e40101051462
publicationDate 2007-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007014124-A3
titleOfInvention High drug load formulations and dosage forms
abstract The invention relates to high drug load formulations containing (R)-2-(2-fluoro-4-biphenylyl)propionic acid as an active pharmaceutical ingredient.
priorityDate 2005-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5192753-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6255347-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5415871-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3394
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414056
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92337

Total number of triples: 36.